Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2013 by Ambit Biosciences Corporation.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Ambit Biosciences Corporation Identifier:
First received: March 27, 2012
Last updated: March 13, 2015
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)